Funding

Neko Health funding news – Stockholm-based Neko Health Secures €250 Million in Series B Round Funding

Jan 23, 2025 | By Kailee Rainse

Neko Health funding news - Stockholm-based Neko Health Secures €250 Million in Series B Round Funding

Neko Health, a healthcare tech company from Stockholm, has raised €250 million in its Series B funding round. The round was led by Lightspeed Venture Partners, with support from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico. As part of the funding, Bejul Somaia from Lightspeed Venture Partners will join Neko Health's Board of Directors.

SUMMARY

  • Neko Health, a healthcare tech company from Stockholm, has raised €250 million in its Series B funding round.
  • Neko Health is a Swedish health-tech company founded in 2018 by Hjalmar Nilsonne and Daniel Ek.

Hjalmar Nilsonne, CEO and Co-Founder of Neko Health, said “We’re at the beginning of a big shift of the healthcare market, from reactive to proactive, driven both by technological advancements and growing consumer demand. This round of financing accelerates Neko’s global expansion of locations to include the US, as well as investments in breakthrough R&D. In the coming years Neko will continue to bring incredible innovations to the market to find and prevent disease before it has a chance to develop.”

On average, 80% of members book and prepay for their next scan at the end of their appointment. The demand is still high, with a global waiting list of over 100,000 people. To meet this demand, the company is expanding by opening more locations and reaching new regions.

Bejul Somaia, Global Partner, Lightspeed Venture Partners, said “After meeting Hjalmar, Daniel and their team, it was clear Neko Health wasn’t just building another healthcare company – they were fundamentally rethinking how we approach prevention. Neko combines breakthrough technology with meticulous attention to detail in everything from their scanning technology to the patient experience. With a long waitlist and a clear path to international expansion, we believe comprehensive preventive care can be both accessible and scalable. Lightspeed is incredibly excited to support Neko Health’s mission of keeping people healthier for longer.”

Neko Health’s latest announcement comes after raising €62.5 million in Series A funding in July 2023, with investors like Lakestar, Atomico, and General Catalyst joining the original investors, Prima Materia.

The company’s goal is to create a healthcare system that helps people stay healthy through prevention and early detection. The Neko Health Scan is a unique, non-invasive test that costs €353 and quickly checks millions of health data points on the body. It looks at moles, skin marks, signs of metabolic issues, and risks for stroke or heart attack, as well as blood sugar levels to check for pre-diabetes.

Read also - VitVio funding news – London-based VitVio has Secured €1.8 Million in Pre-Seed Funding

It also checks for skin cancer and blood issues. After the scan, members get their full results during a doctor-led consultation, all in under an hour.

Neko Health believes that experts agree that focusing on prevention is the best way to tackle the growing health crisis. Since its launch, many experts have pointed to Neko’s scans as a key part of this solution.

Dr Jack Kreindler, Founder of WellFounded and Medical Director of CHHP (Centre for Health and Human Performance), said “In the last two decades, I’ve never seen such a seismic shift in attitudes to personal healthcare, prevention and screening as now. An ever increasing number of my clients have an overarching feeling of “wanting to do more for themselves”,in particular when it comes to screening and preventive health. When I first heard about Neko Health and started sending my clients there, I knew they’d hit the nail on the head from an experience and value for money perspective. Without any bias or incentive, I see that Neko is truly setting new ground – at just the right time to harness a changing self-directed healthcare revolution.”

Dr Vishal Gulati, MD, independent health expert, HealthTech investor, founder and managing partner, Recode Ventures, added: “The greatest challenge in modern healthcare isn’t treating the sick – it’s engaging the healthy. People don’t want to be patients; they want to be participants in their own wellbeing journey. The only way forward is to reimagine healthcare experiences that align with their aspirations of staying well, like Neko Health is doing. Having experienced the Neko Health scan for myself, I’m even more convinced of the need to shift from a system that waits for sickness to one that empowers wellness through experiences like this.”

ABout Neko Health

Neko Health is a Swedish health-tech company founded in 2018 by Hjalmar Nilsonne and Daniel Ek. Their goal is to create a healthcare system that helps people stay healthy through prevention and early detection. To do this, they are rethinking the patient experience and using the latest technology, including sensors and AI.

Recommended Stories for You